This company seems to have been delisted
Reason: Acquired by Novo Holdings and Gurnet Point
Last recorded trade on: November 17, 2023
Source: https://www.reuters.com/markets/deals/novo-holdings-closes-462-mln-acquisition-paratek-pharmaceuticals-2023-09-21/
Reason: Acquired by Novo Holdings and Gurnet Point
Last recorded trade on: November 17, 2023
Source: https://www.reuters.com/markets/deals/novo-holdings-closes-462-mln-acquisition-paratek-pharmaceuticals-2023-09-21/
Paratek Pharmaceuticals
PRTK
C$3.03
Share price
0.00%
Change (1 day)
15.24%
Change (1 year)
Categories
Paratek Pharmaceuticals (PRTK) - Total assets
Total assets on the balance sheet as of June 2023 : C$0.19 Billion
According to Paratek Pharmaceuticals 's latest financial reports the company's total assets are C$0.19 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Paratek Pharmaceuticals - Total assets on balance sheet (from 2004 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | C$0.23 B | -0.09% |
| 2021-12-31 | C$0.23 B | 3.92% |
| 2020-12-31 | C$0.22 B | -31.23% |
| 2019-12-31 | C$0.32 B | -19.81% |
| 2018-12-31 | C$0.40 B | 98.69% |
| 2017-12-31 | C$0.20 B | 12.83% |
| 2016-12-31 | C$0.18 B | -9.89% |
| 2015-12-31 | C$0.20 B | 58.62% |
| 2014-12-31 | C$0.12 B | 62.73% |
| 2013-12-31 | C$78.42 M | -19.57% |
| 2012-12-31 | C$97.5 M | 38.62% |
| 2011-12-31 | C$70.34 M | -4.66% |
| 2010-12-31 | C$73.77 M | -26.36% |
| 2009-12-31 | C$0.10 B | -5.09% |
| 2008-12-31 | C$0.10 B | -3.65% |
| 2007-12-31 | C$0.10 B | 42.43% |
| 2006-12-31 | C$76.91 M | 26.41% |
| 2005-12-31 | C$60.84 M | 5.48% |
| 2004-12-31 | C$57.68 M | |
| 2002-12-31 | C$66.13 M | 971.03% |
| 2001-12-31 | C$6.17 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Spectrum Pharmaceuticals
SPPI | C$0.14 B | -26.14% | 🇺🇸 USA |
 Agenus
AGEN | C$0.27 B | 37.32% | 🇺🇸 USA |
 Ultragenyx Pharmaceutical RARE | C$1.78 B | 799.86% | 🇺🇸 USA |